
Retail investors buy Novo dip after disappointing weight-loss drug data
By Bhanvi Satija (Reuters) – U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Fri...
24th December, 2024

By Bhanvi Satija (Reuters) – U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Fri...
24th December, 2024

By Ankika Biswas (Reuters) – Europe’s STOXX 600 was slightly down at the start of a holiday-shortene...
23rd December, 2024

By Andrew Silver SHANGHAI (Reuters) – As Novo Nordisk and Eli Lilly expand sales of their popular di...
20th December, 2024

By Richa Naidu LONDON (Reuters) – Nestle is launching protein shots in the United States which it sa...
18th December, 2024

By Sruthi Shankar (Reuters) -European shares fell to two-week lows on Tuesday, led by energy and hea...
17th December, 2024

By Deena Beasley (Reuters) – Powerful weight-loss drugs are expanding use of U.S. health care as pat...
16th December, 2024

By Michael Erman NEW YORK (Reuters) -Brian Thompson, the CEO of UnitedHealth’s insurance unit, was f...
6th December, 2024

By Dhwani Pandya MUMBAI (Reuters) – Sweden’s EQT has invested more than its targeted $5 billion in I...
5th December, 2024

By Maggie Fick LONDON (Reuters) – Britain’s drugs cost-effectiveness watchdog NICE said on Thursday...
5th December, 2024

By David Milliken LONDON (Reuters) – British employees whose health deteriorates are four times more...
5th December, 2024

LONDON (Reuters) – Britain’s health security agency (UKHSA) said on Friday another case of the new m...
29th November, 2024

By Ludwig Burger and Stine Jacobsen (Reuters) – Shares of weight-loss drugmakers Novo Nordisk and El...
26th November, 2024